Site is currently under maintenance
Some features may be unavailable or limited during this time. We apologize for any inconvenience and appreciate your patience.

Automated Author Profile

zhengke lian

Current S-Index

1.4

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

0.7

Average Dataset Index per dataset

Total Datasets

2

Total datasets for this author

Average FAIR Score

65.4%

Average FAIR Score per dataset

Total Citations

0

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Metabolomic data of H460 and A549 cells after trametinib treatment

MAP kinse-ERK kinase inhibitor (MEKi) resistance remains unknown. We determined gene expression profiling in MEKi-resistant cells and MEKi-sensitive cells after MEKi treatment using UHPLC-MS/MS.

Authors

  • zhengke lian
0 Citations0 Mentions65% FAIR0.7 Dataset Index
10.17632/54xr9bsxd2January 2023

Metabolomic data of H460 and A549 cells after trametinib treatment

MAP kinse-ERK kinase inhibitor (MEKi) resistance remains unknown. We determined gene expression profiling in MEKi-resistant cells and MEKi-sensitive cells after MEKi treatment using UHPLC-MS/MS.

Authors

  • zhengke lian
0 Citations0 Mentions65% FAIR0.7 Dataset Index
10.17632/54xr9bsxd2.1January 2023